Isolated targeted delivery system for the treatment of ovarian cancer
OwnerMagdalena KROL, Tomasz RYGIEL +5inventors
InventorsMagdalena KROL, Tomasz RYGIEL, Jan BRANCEWICZ, Konrad GABRUSIEWICZ, Waldemar LIPINSKI, Ilona MARSZALEK, Bartlomiej TACIAK
Life of this patent
Estimating the term…
Abstract
The present invention relates to an isolated targeted delivery system comprising a CD45+ leukocyte cell comprising within said cell a complex of one or more iron binding proteins and a pharmaceutically active substance, label or pharmaceutically active substance and label, for use in a method of treatment or diagnosis of ovarian cancer.
Claims20
A method of treating or diagnosing ovarian cancer, comprising administration of an isolated targeted delivery system to a patient in need thereof, wherein the isolated targeted delivery system comprises a CD45+ leukocyte cell comprising within said cell a complex of one or more iron binding proteins and a pharmaceutically active substance, label or pharmaceutically active substance and label.
Dependencies are inferred from the claim text.